eric_terhaerdt_astellas

Astellas takes senior head from AstraZeneca

pharmafile | January 19, 2015 | Appointment | Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing |ย ย Astellas, AstraZeneca, eric Terhaerdtย 

Eric Terhaerdt has been named as the senior vice president of global development operations at Astellas Pharma.

Terhaerdt, who joins the Japanese pharma giant from AstraZeneca where he also served in a vice president capacity, will be located at Astellas’ US headquarters in Illinois.

Reporting in to Dr Bernie Zeiher who is the firmโ€™s executive VP of global development and therapeutic lead, Terhaerdt will be tasked with establishing the direction of its drug development operations in The Netherlands, Japan and the US.

Advertisement

Terhaerdt spent over 20 years with AstraZeneca, serving in a variety of global leadership roles with increasing responsibility in the areas of clinical research, development, quality, strategy and performance along with scientific and technical evaluations.

“Astellas couldn’t be more pleased to have someone with the knowledge and breadth of experience that Eric has,” says Zeiher. “His diverse international experience in drug development, strategic planning and change management will help Astellas continue to address the unmet needs of our patients.”

 

Related Content

Astra Zeneca Logo

NICE recommends Benralizumab for Rare Form of Vasculitis

The National Institute for Health and Care Excellence (NICE) has recommended AstraZenecaโ€™s benralizumab (Fasenra) as …

NICE approves AstraZenecaโ€™s dual immunotherapy for advanced liver cancer

AstraZeneca has received a positive recommendation from the National Institute for Health and Care Excellence …

Astra Zeneca Logo

Purpose and people: the enduring power of brand and the evolution of employer identity

Two decades ago, terms like purpose and people were rarely at the forefront of branding …

The Gateway to Local Adoption Series

Latest content